Acquisition by Spada Alfred P of 106793 shares of Histogen subject to Rule 16b-3
| HSTODelisted Stock | USD 0.03 0.00 0.00% |
About 56% of Histogen's investor base is looking to short. The analysis of current outlook of investing in Histogen suggests that many traders are alarmed regarding Histogen's prospects. Histogen's investing sentiment overview a quick insight into current market opportunities from investing in Histogen. Many technical investors use Histogen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Histogen |
Filed transaction by Histogen Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Histogen Fundamental Analysis
We analyze Histogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Histogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Histogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Histogen is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Histogen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Histogen stock to make a market-neutral strategy. Peer analysis of Histogen could also be used in its relative valuation, which is a method of valuing Histogen by comparing valuation metrics with similar companies.
Peers
Histogen Related Equities
| CRIS | Curis | 11.04 | ||||
| TNXP | Tonix Pharmaceuticals | 2.17 | ||||
| ENTX | Entera Bio | 2.19 | ||||
| PALI | Palisade Bio | 2.56 | ||||
| ARTL | Artelo Biosciences | 2.88 | ||||
| CING | Cingulate | 3.91 | ||||
| DRUG | Bright Minds | 4.01 | ||||
| SONN | Sonnet Biotherapeutics | 6.04 | ||||
| TPST | Tempest Therapeutics | 6.26 | ||||
| VRAX | Virax Biolabs | 6.31 | ||||
| SNTI | Senti Biosciences | 12.91 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Histogen Stock
If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |